Neeraj Agarwal and Rana McKay highlight key studies in urothelial and renal cell carcinomas

The American Society of Clinical Oncology (ASCO) shared on X:

“Neeraj Agarwal of Huntsman Cancer Institute and Rana McKay of UC San Diego look back at ASCO24 by highlighting key studies in urothelial and renal cell carcinomas and other GU cancers on the ASCO Daily News Podcast.”

Yüksel Ürün replied, saying:

“Congratulations Neeraj Agarwal and Rana McKay for the excellent coverage. The detrimental effect observed particularly in patients with high BMI once again answers the question of why we should do clinical research!”

Source: ASCO/X and Yüksel Ürün/X

Neeraj Agarwal is a Professor of Medicine, and a Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI), University of Utah. He also directs the Genitourinary Oncology (GU) Program, and the Center of Investigational Therapeutics (CIT) at the HCI.

Dr. Rana McKay is a board-certified medical oncologist and specializes in urogenital cancers, offering treatment for bladder, kidney, prostate, and testicular cancer patients. Leading a multi-disciplinary prostate cancer clinic at UC San Diego, she ensures comprehensive care through collaboration with urologists and radiation oncologists.

Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. His dedication to patient care and research inspires positive change in the medical field.